BFM
CSII

Boothbay Fund Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Boothbay Fund Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,400
Closed -$243K – 2345
2021
Q3 		$243K Sell
7,400
-108
-1% -$4.03K 0.01% 1461
2021
Q2 		$320K Buy
+7,508
New +$294K 0.01% 1237

Other funds holding CSII

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Boothbay Fund Management's CSII Position: Q4 2021 in Review

Boothbay Fund Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2021, closing a stake of 7,400 shares — an estimated $243K sold.

Boothbay Fund Management first reported a position in CSII in Q2 2021 and held it in 2 quarters. The position peaked at $320K in Q2 2021. 167 funds tracked by Wall St. Rank hold CSII as of Q4 2021.

  • Boothbay Fund Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 7,400 Cardiovascular Systems, Inc. shares in Q4 2021, an estimated $243K.
  • Boothbay Fund Management first reported a position in Cardiovascular Systems, Inc. in Q2 2021 and held it in 2 quarters.
  • Boothbay Fund Management's Cardiovascular Systems, Inc. position peaked at $320K in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.